Acelrx Pharmaceuticals reported $-6739000 in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Acelrx Pharmaceuticals ACRX:US USD -6739000 1.75M
Becton, Dickinson and BDX:US USD 952M 59M
Cara Therapeutics CARA:US USD -23180000 18.97M
Heron Therapeutics HRTX:US USD -41882000 14.48M
Intra Cellular Therapies ITCI:US USD -53507000 33.1M
Johnson & Johnson JNJ:US USD 8.07B 98M
Pfizer PFE:US USD 10.67B 3.11B
Teva Pharmaceutical TEVA:IT USD 768M 1.93B